|
Therapy Area
Protease inhibitor for the treatment of patients with HIV.
|
|
In phase
Preclinical optimization phase in collaboration with Tibotec, Johnson & Johnson. |
Competitive edge
HIV protease inhibitor with highly potent antiviral effect in a cell-based assay are being developed. |
Project data
- Collaboration with Tibotec Pharmaceuticals Ltd. since 30 June 2006
- Inhibitors have very potent activity against both wild-type HIV and resistant virus.
|
|
|
Updated: 28/03/2007
|
